2123-P: Perspectives on Diabetes Technology in Minoritized Families: Findings from the BEAD-T1D Study

Introduction and Objective: Despite advances in diabetes technology (DT), minoritized youth with T1D continue to have lower DT use. Parents/guardians (PG) and youth are central to DT decision making and may have differing perceptions on barriers to DT adoption, particularly in minoritized families. Methods: Youth (n=21) and PG (n=21) participated in interviews/ focus groups in English or Spanish exploring experiences with DT. Transcripts were independently coded by a four-person multilingual team using an iterative process. Themes were compared across youth and PG to identify concordant and divergent perspectives on DT. Results: Three major themes with varying degrees of concordance emerged. Youth and PG diverged in expectations of responsibility: PG questioned youth readiness for consistent DT management, while youth emphasized autonomy and independence. While stigma was identified by youth and PG, it was interpreted differently. Youth emphasized peer perceptions and device visibility, PG focused on safety and social acceptance. Cost was a converging barrier. PG highlighted insurance and long-term affordability, and youth emphasized that cost restricts technology access limiting independence. Conclusion: With varying concordance, youth and PG identified stigma, responsibility, and cost as factors that shape DT use. These data offer strategies to address converging and diverging perspectives of minoritized youth and PG to equitable DT access. Disclosure D. Garfias Silva: None. J. Dixon: None. L. Figg: None. N.L. Arthur: None. A.M. Medina: None. S. Hanes: None. G.M. Shaw: None. D. Naranjo: None. J. Raymond: None. D. Maahs: Advisory Panel; Current; Abbott Diabetes, Sanofi, Medtronic, biospex, enable biosciences, kriya. K. Hood: Consultant; Current; Sanofi, MannKind Corporation, Insulet Corporation. A. Addala: None. Funding NIDDK (5K23DK131342)